Jochelson, US

Daniel S. Jochelson, Dallas, TX US

Patent application number

Description

Published

20090178542

BEAT MATCHING FOR PORTABLE AUDIO - Beat matching for two audio streams extracts beats from each, computes a conversion ratio from one stream to the other stream by an initial beat alignment plus a stability-maintaining beat alignment. A variable resampling converter or time scale modifier adjusts one stream to align beats with those of the other (reference) stream. Thus for cross-fading two music streams the beats of the fading-in stream can be matched to those of the fading-out stream for a seamless transition.

07-16-2009

20100251877

Beat Matching for Portable Audio - Beat matching for two audio streams extracts beats from each, computes a conversion ratio from one stream to the other stream by an initial beat alignment plus a stability-maintaining beat alignment. A variable resampling converter or time scale modifier adjusts one stream to align beats with those of the other (reference) stream. Thus for cross-fading two music streams the beats of the fading-in stream can be matched to those of the fading-out stream for a seamless transition.

10-07-2010

Daniel S. Jochelson, Richardson, TX US

Patent application number

Description

Published

20100188212

Applications for a Two-Way Wireless Speaker System - The two-way wireless speaker system of this invention increases sound fidelity by enabling speakers to acknowledge receipt of audio data packets. This provides increased functionality because the audio hub can receive data not only from wired inputs, but also wireless transmission from computer, cell phone, and other sources. Audio hub can use information from speaker to customize/adjust audio signal for each speaker independently, giving better audio quality and synchronization among speakers.

LOW-DOSE DOXEPIN FOR TREATMENT OF SLEEP DISORDERS IN ELDERLY PATIENTS - Methods of treating sleep disorders, particularly certain aspects of insomnia, in elderly patients (65 years and older) by administering initial daily dosages of doxepin of 1-3 mg. These ultra-low initial dosages are more effective in elderly versus non-elderly patients in decreasing wake time during sleep, latency to persistent sleep and wake time after sleep, and are particularly efficacious in treating those conditions in the last hour of an 8-hour sleep cycle. Also, the dosages described herein are safe for elderly individuals.

LOW-DOSE DOXEPIN FOR TREATMENT OF SLEEP DISORDERS IN ELDERLY PATIENTS - Methods of treating sleep disorders, particularly certain aspects of insomnia, in elderly patients (65 years and older) by administering initial daily dosages of doxepin of 1-3 mg. These ultra-low initial dosages are more effective in elderly versus non-elderly patients in decreasing wake time during sleep, latency to persistent sleep and wake time after sleep, and are particularly efficacious in treating those conditions in the last hour of an 8-hour sleep cycle. Also, the dosages described herein are safe for elderly individuals.

LOW-DOSE DOXEPIN FOR TREATMENT OF SLEEP DISORDERS IN ELDERLY PATIENTS - Methods of treating sleep disorders, particularly certain aspects of insomnia, in elderly patients (65 years and older) by administering initial daily dosages of doxepin of 1-3 mg. These ultra-low initial dosages are more effective in elderly versus non-elderly patients in decreasing wake time during sleep, latency to persistent sleep and wake time after sleep, and are particularly efficacious in treating those conditions in the last hour of an 8-hour sleep cycle. Also, the dosages described herein are safe for elderly individuals.